DiscoverTalking Precision MedicineMichelle Chen | Using AI to derisk gene therapy and genetic medicine | TPM podcast #51
Michelle Chen | Using AI to derisk gene therapy and genetic medicine | TPM podcast #51

Michelle Chen | Using AI to derisk gene therapy and genetic medicine | TPM podcast #51

Update: 2025-11-13
Share

Description

In this episode Rafael sits down with Michelle Chen, President and CEO of Form Bio, a techbio company using AI to advance genome engineering and the development of genetic medicines. Michelle shares her zigzag journey from scientist to executive, how her team is tackling the biggest bottlenecks in gene therapy, and why AI has become essential in designing safer, more effective treatments.

⁠⁠TPM E51 highlights >⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Episode 51 links:


Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Michelle Chen | Using AI to derisk gene therapy and genetic medicine | TPM podcast #51

Michelle Chen | Using AI to derisk gene therapy and genetic medicine | TPM podcast #51

Genialis